
Fake medicine hits retail investors hard
Individual investors took a severe beating from the fake herbal medicine produced by Naturalendo Tech, with their combined investment losses estimated at more than 600 billion won ($559 million).
“About 9,400 retail investors held a combined 54 percent stake in Naturalendo Tech as of the end of last year. They likely suffered hefty losses as the company’s stock prices fell sharply Thursday after the authorities said the herbal medicine contained uncertified ingredients,” an official at the tech-heavy KOSDAQ market said.
http://www.koreatimes.co.kr/www/news/biz/2015/05/488_178130.html
Related Posts
HMSI takes action against counterfeit parts, raids 2 locations in Mumbai
The company says the police seized over 1,500 fake parts with an estimated value...
Anti-Counterfeit Packaging Market To Reach USD 248.90 Billion By 2026.
Anti-Counterfeit Packaging Market Size – USD 111.70 Billion in 2018, Market...
Illicit trade, fakes burn cigarette firms’ revenue
India is fifth largest market of illicit cigarettes, says Euromonitor. Organised...
HOMAI re-launched as ASPA, resolves to fight counterfeiting
Hologram Manufacturers Association of India (HOMAI), which was founded in 1998 to...

